Effects of a Phytoestrogen Intervention and Estrogen Receptor β Genotype on Prostate Cancer Proliferation and PSA Concentrations-A Randomized Controlled Trial.

Journal

Nutrition and cancer
ISSN: 1532-7914
Titre abrégé: Nutr Cancer
Pays: United States
ID NLM: 7905040

Informations de publication

Date de publication:
28 Sep 2024
Historique:
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: aheadofprint

Résumé

A phytoestrogen-rich diet has been suggested to reduce tumor proliferation among men with prostate cancer, and the effect may differ between men with different polymorphisms of the estrogen receptor-beta gene (ERβ). Patients with low- or intermediate-risk prostate cancer scheduled for radical prostatectomy were randomized to an intervention group (

Identifiants

DOI: 10.1080/01635581.2024.2407007 PMID: 39340410
pubmed: 39340410
doi: 10.1080/01635581.2024.2407007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-15

Auteurs

Rebecca Ahlin (R)

Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Cancer Rehabilitation, Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Andreas Josefsson (A)

Sahlgrenska Cancer Center, Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden.
Department of Diagnostics and Interventions, Urology, Umeå University, Umeå, Sweden.

Sanna Nybacka (S)

Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Rikard Landberg (R)

Division of Food and Nutrition Science, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.

Johan Stranne (J)

Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Gunnar Steineck (G)

Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Maria Hedelin (M)

Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH